MicrobeWorld App

appsquarebannerad200x200

ASM Fellowships

Fellowship

Microbes After Hours

Watter-Supply-200x200-Banner

Click for more "Microbes After Hours" videos

Join MicrobeWorld

Subscribe via Email

subscribe

Featured Image

Featured Video

Ebola Virus explained

Supporters

ASM House 200X200

Cross-Reactive Antibodies Vanquish H5N1 in Preclinical Study

The H5N1 influenza has proven extraordinarily deadly. More than 50 percent of the 500 cases that have been documented since the virus first emerged in 1997 have been fatal. Thus, H5N1 is viewed as a serious threat to world public health. A major difficulty in developing antibodies to combat this virus is that ten different antigenic types have evolved since the virus first emerged. But now a team of researchers has produced a so-called cross-reactive antibody that can bind to nine of the ten H5N1 groups. They showed further that it could protect mice from infection, and that it could be used to treat established infections in the mice. The research is published in the March Journal of Virology.

Click "source" to read more.

Tips from the Journals of the American Society for Microbiology - March 2012 (http://www.asm.org/index.php/news-room/journal-tipsheets.html)
 
 

Comments (0)

Collections (0)

 

American Society for Microbiology
2012 1752 N Street, N.W. • Washington, DC 20036-2904 • (202) 737-3600
American Society For Microbiology © 2014   |   Privacy Policy   |   Terms of Use